Numeric Investors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Numeric Investors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-45,300	Closed	-$766K	–	1236
2017 Q2	$766K	Sell	45,300 -892,185	-95%	-$13.6M	0.01%	730
2017 Q1	$12.5M	Buy	937,485 +919,941	+5,244%	+$14.4M	0.11%	200
2016 Q4	$264K	Sell	17,544 -24,005	-58%	-$317K	﹤0.01%	945
2016 Q3	$486K	Sell	41,549 -495,181	-92%	-$5.82M	﹤0.01%	780
2016 Q2	$5.8M	Sell	536,730 -162,068	-23%	-$1.67M	0.05%	289
2016 Q1	$6.46M	Sell	698,798 -351,995	-33%	-$3.79M	0.07%	259
2015 Q4	$15.6M	Buy	1,050,793 +703,893	+203%	+$11.8M	0.17%	139
2015 Q3	$5.69M	Sell	346,900 -50,850	-13%	-$1.04M	0.07%	232
2015 Q2	$9.07M	Buy	+397,750	New	+$7.92M	0.1%	178
2015 Q1	–	Sell	-262,066	Closed	-$3.15M	–	1102
2014 Q4	$3.15M	Buy	262,066 +207,919	+384%	+$2.38M	0.04%	295
2014 Q3	$614K	Sell	54,147 -166,293	-75%	-$1.9M	0.01%	542
2014 Q2	$2.66M	Buy	+220,440	New	+$2.6M	0.04%	309

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Numeric Investors's MNTA Position: Q3 2017 in Review

Numeric Investors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2017, closing a stake of 45,300 shares — an estimated $766K sold.

Numeric Investors first reported a position in MNTA in Q2 2014 and held it in 12 quarters. The position peaked at $15.6M in Q4 2015. 158 funds tracked by Wall St. Rank hold MNTA as of Q3 2017.

Numeric Investors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Numeric Investors sold 45,300 Momenta Pharmaceuticals, Inc. shares in Q3 2017, an estimated $766K.
Numeric Investors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 12 quarters.
Numeric Investors's Momenta Pharmaceuticals, Inc. position peaked at $15.6M in Q4 2015.
158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2017.

Based on Numeric Investors's 13F filing for Q3 2017, filed 14 Nov 2017.